Hilal Taymaz-Nikerel

6PUBLICATIONS
8CO-AUTHORS
Electrical energy generation (incl. renewables, excl. photovoltaics)Molecular targetsMultiphysics flows (incl. multiphase and reacting flows)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 23, 2024
Increasing the Pentose Phosphate Pathway Flux to Improve Plasmid DNA Production in Engineered E. coli.

Mitzi de la Cruz, Flavio Kunert, Hilal Taymaz-Nikerel

|Aug 03, 2023
Doxorubicin-induced transcriptome meets interactome: identification of new drug targets.

Hilal Taymaz-Nikerel

|Jan 21, 2022
Vitreoscilla Haemoglobin: A Tool to Reduce Overflow Metabolism.

Hilal Taymaz-Nikerel, Alvaro R Lara

|Jul 19, 2021
Integration of fluxome and transcriptome data in Saccharomyces cerevisiae offers unique features of doxorubicin and imatinib.

Hilal Taymaz-Nikerel

|Jun 22, 2021
Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection.

Arzu Cakir, Melisa Tuncer, Hilal Taymaz-Nikerel

|Jun 07, 2021
Time-dependent re-organization of biological processes by the analysis of the dynamic transcriptional response of yeast cells to doxorubicin.

Muhammed Erkan Karabekmez, Hilal Taymaz-Nikerel, Serpil Eraslan

Pageof 1

Frequent Collaborators

2 joint publications

Alvaro R Lara

1 joint publications

Muhammed Erkan Karabekmez

1 joint publications

Betul Kirdar

1 joint publications

Arzu Cakir